A detailed history of Intrepid Family Office LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Intrepid Family Office LLC holds 30,000 shares of IOVA stock, worth $112,500. This represents 0.24% of its overall portfolio holdings.

Number of Shares
30,000
Holding current value
$112,500
% of portfolio
0.24%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$7.17 - $12.28 $215,100 - $368,400
30,000 New
30,000 $222,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $592M
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Intrepid Family Office LLC Portfolio

Follow Intrepid Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrepid Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrepid Family Office LLC with notifications on news.